Sonoma Pharmaceuticals Inc. (SNOA) expanding its growth trajectory ahead

With 1.01 million shares changed hands, the volume of the stock remained lighter than its average volume of 2.3 million shares. During the session, the Drug Manufacturers – Specialty & Generic company that operates in wider Healthcare sector, reached to the highest price of $0.2186 whereas the lowest price it dropped to was $0.2024. The 52-week range on SNOA shows that it touched its highest point at $1.52 and its lowest point at $0.12 during that stretch. It currently has a 1-year price target of $3.25. Beta for the stock currently stands at 1.37.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of SNOA was up-trending over the past week, with a rise of 5.68%, but this was up by 34.54% over a month. Three-month performance surged to 39.87% while six-month performance rose 5.63%. The stock lost -78.52% in the past year, while it has gained 15.52% so far this year.

Float and Shares Shorts:

At present, 15.61 million SNOA shares are outstanding with a float of 15.38 million shares on hand for trading. On 2024-05-15, short shares totaled 74331.0, which was 47.999998000000005 higher than short shares on 1713139200. In addition to Ms. Amy M. Trombly as the firm’s CEO, President & Director, Mr. Jerome J. Dvonch serves as its Chief Financial Officer.

Institutional Ownership:

Through their ownership of 0.01053 of SNOA’s outstanding shares, institutional investors have minority control over the company.

An Overview of Recent Financials:

Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2023-12-31, SNOA reported revenue of $3138000.0 and operating income of -$844000.0. The EBITDA in the recently reported quarter was -$799000.0 and diluted EPS was -$0.08.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for SNOA since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.